Navigate
X
    QualityStocks
  • 17 years ago

EpiCept Corporation (NASDAQ: EPCT)

EpiCept Corporation (NASDAQ: EPCT), a specialty pharmaceutical company, is focused on meeting unmet medical needs in cancer treatment and pain management. The company has approval from the European Commission to use Ceplene for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia in first remission. Additionally, EpiCept is utilizing its biopharmaceutical discovery capabilities for the discovery and advancement of apoptosis inducers. For further information, visit the Company’s web site at www.epicept.com.

Tags Rodman & Renshaw
Related Post
  1. New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Looks Forward to Bolivia Presidential Runoff, Hoping for Increased Foreign Investment Support

    Bolivia heads into an October presidential runoff, signaling a possible shift toward more pro-business policies,…

  2. Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF): Building Value Through Nevada’s Walker Lane

    Four-property portfolio in Nevada’s Walker Lane anchored by the Santa Fe Mine project with over…

  3. ONAR Holding Corp. (ONAR) Powers Smarter Marketing with Agency Innovation

    As budgets tighten and demands intensify, CMOs are questioning traditional marketing models ONAR is seizing…